Atlas Trials

Clinical Trial of Efficacy and Safety of the Combination of Reduced Duration Prophylaxis Followed by Immuno-guided Prophylaxis in Lung Transplant Recipients.

Clinical trial NCT03699254 · COMPLETED

Trial details

NCT number
NCT03699254
Sponsor
Maimónides Biomedical Research Institute of Córdoba
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Transplantation InfectionCytomegalovirus Infections
Start date
2019-04-05
Primary completion
2023-05-29
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.